| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.3M | -4.8% |
| Cost of Revenue | $14.6M | +4.8% |
| Gross Profit | $695K | -67.3% |
| R&D Expense | $1.2M | -16.3% |
| SG&A Expense | $4.3M | -9.2% |
| Operating Income | -$6.0M | -8.3% |
| Interest Expense | $559K | +863.8% |
| Net Income | -$6.5M | -17.3% |
| EPS (Basic) | -$0.49 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $549K | +160.2% |
| Accounts Receivable | $1.7M | -24.8% |
| Inventory | $16.5M | +6.9% |
| Current Assets | $22.0M | -5.7% |
| Total Assets | $25.3M | +4.4% |
| Current Liabilities | $10.2M | +71.7% |
| Long-term Debt | $64K | -76.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | +47.3% |
| Capital Expenditures | $194K | +676.0% |
| Investing Cash Flow | -$194K | -676.0% |
| Financing Cash Flow | $4.0M | +141.3% |
| Free Cash Flow | -$3.6M | +44.5% |
| -14.0% |
| EPS (Diluted) | -$0.49 | -14.0% |
| Total Liabilities |
| $12.1M |
| +100.9% |
| Stockholders' Equity | $13.2M | -27.5% |